Clinical Management of Fungal Biofilm Infections

Fungal biofilms are highly resilient to antifungal therapies, of which there are relatively few licensed options available in clinical medicine. Nonetheless, there is a vibrant research culture aimed at enhancing and expanding the arsenal of antifungals capable of inhibiting, killing, and disrupting...

Full description

Saved in:
Bibliographic Details
Published inAntibiofilm Strategies pp. 441 - 465
Main Authors Ramage, Gordon, Short, Bryn, McKloud, Emily, Alshanta, Om Alkhir, Butcher, Mark, McLean, William, Brown, Jason L.
Format Book Chapter
LanguageEnglish
Published Cham Springer International Publishing
SeriesSpringer Series on Biofilms
Subjects
Antifungal
Azole
Biofilm
Candida
Polyene
Online AccessGet full text

Cover

More Information
Summary:Fungal biofilms are highly resilient to antifungal therapies, of which there are relatively few licensed options available in clinical medicine. Nonetheless, there is a vibrant research culture aimed at enhancing and expanding the arsenal of antifungals capable of inhibiting, killing, and disrupting fungal biofilms. This chapter aims to explore the wide variety of fungal biofilms affecting human health and to discuss the clinical options for existing and novel chemotherapeutics.
ISBN:3031109910
9783031109911
ISSN:1863-9607
1863-9615
DOI:10.1007/978-3-031-10992-8_17